tbuckley/cabot-search huggingface dataset:
Correction: Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age
Journal: Annals of Internal Medicine (2001)

Corrections3 July 2001Correction: Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of AgeFREESearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-1-200107030-00042 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In a recent article on risk factors for coronary heart disease in 18- to 39-year-old men (1), the first line of the figure legend should read “Receiver-operating characteristic curves for prediction of fatal coronary heart disease in young men over 20 years,” not “Receiver-operating characteristic curves … in young men older than 20 years of age.”Reference1. Navas-Nacher EL, Colangelo L, Beam C, Greenland P. Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med. 2001;134:433-9. [PMID: 11255518] LinkGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRisk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age Elena L. Navas-Nacher , Laura Colangelo , Craig Beam , and Philip Greenland Metrics 3 July 2001Volume 135, Issue 1Page: 71KeywordsCoronary heart diseaseMedical risk factors ePublished: 3 July 2001 Issue Published: 3 July 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
THE HOME TREATMENT OF CONSUMPTIVES.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Preliminary results of a prospective pilot program for transplantation of patients with alcohol-related liver disease and less than 6 months abstinence
Authors: Lauren Carrique, Jill Quance, Isabel Sales, Les Lilly, Zita Galvin, Mamatha Bhat, Susan Abbey, Adrienne Tan, Josee Lynch, Nazia Selzner
Journal: Journal of Hepatology (2020)
Hypnotism.
Authors: E. Chenery
Journal: JAMA (1890)

<h3>To the Editor:</h3> —I think you have done the profession a good service in bringing before it the excellent paper by Dr. Lackersteen on " Hypnotism," with the comments upon it by the able gentlemen who spoke at its conclusion. I regard as in the right line the suggestion of Dr. Lackersteen that a judicious committee be created to examine into the uses of the hypnotic state, together with its abuses also, and give public, authoritative protests against popular exhibitions of it by wandering mountebanks. As a popular affair the whole thing, in my judgment, should be stamped out as dangerous and destructive. I had occasion, some years ago, to attend some of the exhibitions given by Carpenter in Tremont Temple. He had found in his travels several facile subjects, which he took from place to place, and with whom he did his most marvelous feats. His chief dupe was a
Some Recent Events of Special Interest to Medical Education
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
6-Thioguanine measurement allows optimisation in management of IBD patients on azathioprine
Authors: G. E. Dolman, H. E. Johnson, S. D. McLaughlin, J. P. Begley, S. A. Weaver
Journal: Gut (2011)

<h3>Introduction</h3> Azathioprine is widely used in the management of Inflammatory Bowel Disease (IBD). The ideal dose for a patient is usually calculated by weight, but the rate of metabolism of azathioprine to its active metabolite 6-thioguanine (6TGN) varies between individuals. In addition, therapy may be limited by non-compliance, side effects or relapse of disease while on treatment. This retrospective study evaluates whether measuring 6TGN levels alters the management of patients on azathioprine for IBD. <h3>Methods</h3> A search of laboratory records identified a cohort of 41 patients with IBD that had been tested for 6TGN levels. 48 tests had been performed as 7 patients were tested twice. Electronic and, when required, paper records were reviewed to record demographics and diagnosis. The reason for checking 6TGN level and how this altered management was evaluated. <h3>Results</h3> The cohort was mainly young adults, with an age range of 18–73 years (median 36 years), and a slight female predominance (22 F:19 M). 66% of patients had Crohn9s disease, the remainder Ulcerative Colitis (UC). Tests were performed because patients were symptomatic, suspected of non-compliance, had abnormal liver biochemistry or to confirm a therapeutic dose. Of the 48 tests performed, 12 (25%) identified low 6TGN levels. Compliance was addressed in 3 cases. Dose of azathioprine was increased in 6 cases and management was altered in 2 cases. 20 tests (42%) were within the therapeutic range and azathioprine dose was only increased following 3 of these tests. 4 patients required escalation of treatment to alternative medication or surgery. 16 tests (33%) were above the recommended level of 6TGN, despite all the patients receiving &lt;2.7 mg/kg of azathioprine and 4 patients receiving less than 2 mg/kg. 5 patients with high 6TGN levels were subsequently switched to an alternative agent for maintenance therapy. 29 (60%) of all tests were performed on symptomatic patients to confirm adequate dosing before declaring a treatment failure. By weight calculation, 11 of these patients were receiving subtherapeutic doses of azathioprine. However, contrary to expectation, only 5 of 11 had low levels of 6TGN. <h3>Conclusion</h3> Calculation of azathioprine dose by weight does not address individual variation in metabolism to the active component, 6TGN. In this retrospective study, management was altered in 51% of patients as a result of measuring 6TGN, with either alteration of dose, or change of therapy. The cost of the assay (£29) limits its use, and currently we would recommend the use of 6TGN as a useful adjunct to established measures for azathioprine dose adjustment, such as clinical response and haematological indices.
Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Aversion therapy. Council on Scientific Affairs
Journal: JAMA (1987)

Aversion therapy is a series of techniques designed to reduce unwanted or dangerous behaviors. The most common applications of these techniques are to obesity, tobacco smoking, sexuality, oral habits, self-injurious and aggressive behaviors, and substance abuse. Most enthusiastic reports suffer from lack of control groups and control procedures. At this time, the best accepted application is for the treatment of chronic self-injurious behavior.The report on aversion therapy by the American Medical Association's (AMA) Council on Scientific Affairs was submitted to the AMA House of Delegates in June 1987 as an informational report and is not intended to serve as a standard of care. It reflects the views of the scientific literature as of February 1987. Aversive techniques designed to reduce dangerous or unwanted behaviors are applied most commonly to obesity, smoking, alcoholism and drug abuse, sexual behavior, and self-injurious and aggressive behavior in the mentally retarded. Specific techniques that have obtained the most positive results in some of these areas are described. The report notes, however, that carefully designed and controlled studies are needed before definitive conclusions can be drawn.
Ireland
Journal: BMJ (1912)

That this meeting of medical men-i practiising in East Lotliian herewith resolves itself inlto tlhe "East Lothian Medical Associatioi"; that the general purpose of the proposed associationi be an organized uinioln of the mliedical practi- tioners of East Lothian for thje pI)urpose of protecting the interests of the professton and of streingtheniing the bonds of professionial fellowship.It was remitted to a commiiittee of eiglht, one-third of the total nunuber of Er ctitioners in thle couiity, to draw up a conistitution to sutnit to a futuire mueetinig.It was fuLrther agreed to intimate witlhout delay to the Scottish Commis- sioners tlhat, unless the six cardinal points of the Britislh Medical Association were fully embodied in the draft regulations to be drawn up by thlenm for the working of the Act, no practitioner in East Lotlhian will go uipon the panel.ITnccrn( ss-sht ire Practitionzers.At a largaely-attenlded me-leetineg of tlle medical prac- titioners of tlle tow%vn and county of Inverness, on Friday, December 29th, 1911,-the follow,ving resolutions were unanimuously adopted, and a copy was sent to the Scottish Com-imissioners, who are to carry ouLt the provisions of tlhe National Insurance Act:
ORAL POLIOVACCINE
Authors: H K BEECHER
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Table of contents
Journal: Hepatology (2018)

Cover Figure: Cirrhotic cardiomyopathy in end stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease.This figure illustrates a cirrhotic liver restricting the heart filling, depicting the concept of diastolic dysfunction in cirrhotic cardiomyopathy.See concise review on page 2008.
Acute schistosomiasis among Americans rafting the Omo River, Ethiopia
Authors: G. R. Istre
Journal: JAMA (1984)

An outbreak of acute schistosomiasis occurred among a group of adventurers who took part in a rafting expedition on the Omo River in Ethiopia in November 1981. Six (55%) of the 11 members of the expedition experienced<i>Schistosoma mansoni</i>infection confirmed by stool examination. Five of these six had symptoms compatible with acute schistosomiasis. Eosinophilia was the most frequent sign of infection (five of six), and fever, the most common symptom (four of six). Despite medical evaluations, illnesses had remained undiagnosed until January 1982. This outbreak should alert physicians to the risk of schistosomiasis among travelers to this part of Africa and the difficulty of correct diagnosis early in the course of the disease. (<i>JAMA</i>1984;251:508-510)
Obesity Paradox?
Authors: Ross S. Summer
Journal: American Journal of Respiratory and Critical Care Medicine (2013)

The obesity paradox is a phrase often used to describe the curious epidemiological finding that obese individuals are somehow predisposed to the development of disease, but outcomes once the disease is established are improved when compared with lean counterparts.The obesity paradox has been described in association with various cardiovascular conditions, but recently, a similar phenomenon was reported in patients with acute lung injury (1-3).However, because of the complexity of reading chest radiographs from obese individuals (e.g., because of atelectasis, increased soft-tissue density, and low lung volumes) many experts believe that "predisposition" as well as "improved outcomes" may be explained, at least in part, by the fact that acute lung injury is overdiagnosed in obese individuals.It is for this reason I was disappointed to find out that body mass index was not included in the excellent study by Thille and colleagues published in the Journal (4).If the authors collected data on height and weight, could they kindly evaluate whether an inverse association between obesity and diffuse alveolar damage pathology was observed in their study?
J Nervous and Mental Disease, Baltimore
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ethnic Identification
Authors: RAFAEL J. IGARTUA
Journal: Annals of Internal Medicine (1973)

Comments and Corrections1 April 1973Ethnic IdentificationRAFAEL J. IGARTUA, M.D.RAFAEL J. IGARTUA, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-78-4-614 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In a brief communication, "Survival with Carcinoma of the Esophagus," in the December 1972 issue (pp. 915-918), the following appeared under the heading "Age and Race": "Most of the nonwhite patients were negroes, a few were Puerto Ricans, and a few Orientals." I object to this information for these reasons:1. People who have been born in Puerto Rico do not constitute a separate race, any more than people who have been born in New York, California, or other regions of the United States. People who have been born in Puerto Rico are of European or African... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByProblems with surveillance methods for alcoholism: differences in coding systems among federal, state, and private agencies.The risk of sudden death in sickle cell trait: Noninvasive assessment of cardiac response to exercise 1 April 1973Volume 78, Issue 4Page: 614-614KeywordsEsophagusHispanic peopleRacial and ethnic issues Issue Published: 1 April 1973 PDF DownloadLoading ...
MELLON ISSUES BEER REGULATIONS
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Oxygen and athletes
Authors: K. H. Cooper
Journal: JAMA (1989)

Small increments in performance can be the difference between winning and losing an athletic contest. Coaches and athletes constantly seek methods to produce these increments by improved training techniques or ergogenic aids. Many ergogenic aids are banned in competition and during training by sports governing bodies, but breathing oxygenrich air is permitted during recovery in many sports. It is common to see a college or professional football player come to the sidelines, place a mask over his nose and mouth, and breathe from an oxygen tank. Coaches and players apparently believe that this procedure hastens recovery and will permit the athlete to return to competition with renewed vigor. Priestley himself said "I fancied that my breast felt peculiarly light and easy for some time afterwards [after breathing 100% oxygen]" (as reported by Welch).<sup>1</sup> Furthermore, many years ago, Hill and Flack<sup>2,3</sup>suggested that supplemental oxygen might speed recovery from
TAMOXIFEN PROPHYLAXIS
Authors: J.-C. Gazet, V.E. Basco, C.M.L. Coppin, P.M. Rebbeck, MichaelJ. Daly, Wilson Wong, M.C. Pike, M.P. Coleman, Philip Milner, Ian Johnson, Stephen Birch, Brian Williams, H.W. Simpson, W. Candlish
Journal: The Lancet (1986)
The "Incompetent and Inefficient" Medical Department of the Army.
Authors: None A. L. G.
Journal: JAMA (1898)

New York, Aug. 27, 1898. <h3>To the Editor:</h3> —I have all along sympathized with Surgeon-General Sternberg for the load he has had to bear; but I did not fully appreciate the bearing of his burthen until I read the letter in your issue of August 20, (pp. 421-3). The wail of the "<i>Late</i>Major and Surgeon" [<i>hinc illæ lachrymæ</i>] recalls the complaint of the governor of a great State that the medical officers of the regiments from that State "could not get their prescriptions filled," who, when confronted with the Army Medical Supply Table, and told that it was the fault of those officers if they lacked anything, said: "Oh, yes, I have seen that, but I would like you to show me lactopeptin on it." "<i>Lactopeptin!</i>What would they want with lactopeptin?" "Why," said he, "most of these men have not been accustomed to the coarse army fare and
Varicella Vaccination Rate Improves
Journal: JAMA (2014)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal